| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_699173aeb7373fb9376c05ed8d9e0f31 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 |
| filingDate |
2003-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_507a035d699292db0a0b48e0431d46fb |
| publicationDate |
2005-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005245549-A1 |
| titleOfInvention |
Combination of vegf receptor tyrosine kinase inhibitors for treatment of cancer |
| abstract |
The present invention relates to a method for the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human which is optionally being treated with ionising radiation, particularly a method for the treatment of a cancer, particularly a cancer involving a solid tumor, which comprises the administration of ZD6474 in combination with ZD1839; to a pharmaceutical composition comprising ZD6474 and ZD1839; to a combination product comprising ZD6474 and ZD1839 for use in a method of treatment of a human or animal body by therapy; to a kit comprising ZD6474 and ZD1839; to the use of ZD6474 and ZD1839 in the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human which is optionally being treated with ionising radiation. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010130520-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011212978-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010069398-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006167027-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007258976-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7173038-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007265286-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8642608-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010029673-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010092466-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9040548-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006223815-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10457664-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005043395-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003144298-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7829573-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011086870-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008269261-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008200436-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010215773-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010120708-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010130493-A1 |
| priorityDate |
2002-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |